Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/PRS.0000000000006944 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to Nadir I. Osman, Christopher R. Chapple, Sheila MacNeil's Letter to the Editor re: Guido Barbagli, Massimo Lazzeri. Clinical Experience with Urethral Reconstruction Using Tissue-engineered Oral Mucosa: A Quiet Revolution. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.043.
Eur Urol
November 2015
Department of Urology, Humanitas Clinical and Research Centre, Humanitas University, Rozzano (Milan), Italy. Electronic address:
Reply: Tissue-Engineered Breast Reconstruction with Brava-Assisted Fat Grafting: A 7-Year, 488-Patient, Multicenter Experience.
Plast Reconstr Surg
October 2015
Miami Breast Center and Herbert Wertheim College of Medicine at Florida, International University, Miami, Fla. Unita di Chirurgia Rigenerativa, Clinica San Francesco, Verona, Italy Miami Breast Center, Miami, Fla., and University of Michigan Medical School, Ann Arbor, Mich. Baylor College of Medicine, Houston, Texas.
Regulation of advanced therapy medicinal products in Europe and the role of academia.
Cytotherapy
March 2014
Department of Haematology, Royal Free Hospital & University College London, United Kingdom. Electronic address:
Background Aims: Advanced therapy medicinal products (ATMP) are gene therapy, somatic cell therapy or tissue-engineered products regulated under (EC) No. 1394/2007 to ensure their free movement within the European Union while guaranteeing the highest level of health protection for patients. Academic good manufacturing practice (GMP) centers are major contributors in the development of ATMPs and this study assessed the impact of regulations on them.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!